Scout | High-Risk HIV and Substance Use Research Awards (DP1), Optional Clinical Trial

This opportunity is no longer accepting applications.

grant

High-Risk HIV and Substance Use Research Awards (DP1), Optional Clinical Trial

This funding opportunity supports innovative basic, clinical, translational, and implementation research focused on HIV and substance use. It targets high-risk, high-reward studies that can lead to breakthroughs in prevention, diagnosis, treatment, and HIV suppression for people who use substances and/or have substance use disorder. A DP1 mechanism is included with an optional focus on clinica…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Program: National Institute on Drug Abuse

Dates

Release Date: June 9, 2026

Expiration Date: September 26, 2028

Keywords

hiv research

substance use

high risk high reward

clinical trial

translational science

implementation science

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers